- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01206543
1.5T Intraoperative MR Imaging in Craniopharyngiomas
September 21, 2010 updated by: Hofmann, Bernd, M.D.
Intraoperative Use of a MR Tomography System Combined With Neuronavigation - Analysis of the Craniopharyngioma Subgroup ("Intraoperative Nutzung Eines Kernspintomographie-Systems in Direkter Kopplung Mit Einem Neuronavigations-System")
Purpose of this study is to investigate whether intraoperative imaging using a 1.5T MRI in craniopharyngioma surgery is useful in order to increase the rate of complete tumor removal.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Erlangen, Germany, 91052
- Department of Neurosurgery University of Erlangen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 75 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- complex craniopharyngioma > 1cm extension within 2 or more cranial fossae or ventricular system
- Patient or legal representative able to provide written informed consent
Exclusion Criteria:
- tumor size< 1 cm
- Patients with any condition considered a contraindication to MRI
- Patients with any condition considered a contraindication for surgery
- Hypothalamic disturbances
- Hypothalamic edema
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intraoperative imaging
|
Intraoperative imaging and determination of degree of resection / complete tumor removal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of additional tumor removal
Time Frame: up to 3-4 months following surgery
|
Number of patients in whom non suspected tumor remants were indicated by intraoperative MRI and remnants could be removed completely thereafter.
Results have to be confirmed in 1st follow up imaging.
|
up to 3-4 months following surgery
|
Rate of achievement of intended extent of removal
Time Frame: up to three months following surgery
|
It is examined whether the extent of tumor removal defined prior to surgery was achieved
|
up to three months following surgery
|
Diagnostic reliability
Time Frame: within 3 -4 months following surgery
|
false positive or negative interpretation of intraoperative imaging determined after follow-up imaging 3 - 4 months following surgery
|
within 3 -4 months following surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Surgical complication
Time Frame: within 1st week following surgery
|
Rate of new deficits following surgery (excluding new endocrine deficits)
|
within 1st week following surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bernd Hofmann, MD
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2002
Primary Completion (Actual)
September 1, 2005
Study Completion (Actual)
August 1, 2006
Study Registration Dates
First Submitted
September 20, 2010
First Submitted That Met QC Criteria
September 21, 2010
First Posted (Estimate)
September 22, 2010
Study Record Updates
Last Update Posted (Estimate)
September 22, 2010
Last Update Submitted That Met QC Criteria
September 21, 2010
Last Verified
September 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cranio 15
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Craniopharyngioma
-
Nationwide Children's HospitalChildren's Hospital ColoradoRecruitingAdamantinous Craniopharyngioma | Recurrent Adamantinomatous CraniopharyngiomaUnited States, United Kingdom, Australia, Canada, Germany, Netherlands
-
Nationwide Children's HospitalChildren's Hospital ColoradoRecruitingAdamantinomatous Craniopharyngioma | Recurrent Adamantinomatous CraniopharyngiomaUnited States, United Kingdom, Australia, Canada, Germany, Netherlands
-
Sabine Mueller, MD, PhDBristol-Myers Squibb; Day One Biopharmaceuticals, Inc.RecruitingCraniopharyngioma | Craniopharyngioma, Child | Recurrent CraniopharyngiomaUnited States
-
University of Colorado, DenverEnrolling by invitationCraniopharyngioma, ChildUnited States
-
BERTHILLIER JulienCompletedChildren With a Craniopharyngioma
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingVemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive CraniopharyngiomaBRAF V600E Mutation Present | Papillary CraniopharyngiomaUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)TerminatedChildhood CraniopharyngiomaUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI)Recruiting
-
Huashan HospitalCompletedAdult-onset Craniopharyngioma | Postoperative Weight GainChina
-
Eva Marie Erfurth, MD, PhDNovartisRecruiting
Clinical Trials on Intraoperative imaging using 1.5T MRI
-
Leiden University Medical CenterUnknown
-
Mayo ClinicNational Institute on Aging (NIA)Completed
-
Children's Hospital Medical Center, CincinnatiCompletedHealthy Volunteers | Musculoskeletal ComplicationUnited States
-
Turku University HospitalUnknownFacial Asymmetry | Jaw DeformityFinland
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
Second Affiliated Hospital, School of Medicine,...UnknownMyocardial Injury | Osteosarcoma | Cardiotoxicity | Doxorubicin Induced Cardiomyopathy | Chemotherapy Induced Systolic DysfunctionChina
-
Cliniques universitaires Saint-Luc- Université...Recruiting
-
University of LeicesterUniversity Hospitals, LeicesterCompleted
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Goethe UniversityCompleted